FCM
THRX

Farallon Capital Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Farallon Capital Management’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-223,149
Closed -$1.29M – 261
2022
Q3 		$1.29M Sell
223,149
-186,568
-46% -$1.08M 0.01% 210
2022
Q2 		$2.27M Sell
409,717
-114,262
-22% -$632K 0.01% 206
2022
Q1 		$6.04M Hold
523,979
– – 0.03% 174
2021
Q4 		$6.64M Buy
+523,979
New +$6.64M 0.03% 167